Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
PDF) The Role of Oxidative Stress and Therapeutic Potential of
Proposal for Standardization of Primary and Secondary Outcomes in
Effect of dapagliflozin on the rate of decline in kidney function
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label
Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and
Lancet子刊：万能药他汀又来了，甲亢突眼它也能治！@MedSci
Management of thyroid eye disease: a Consensus Statement by the
Effect of dapagliflozin on the rate of decline in kidney function
Effect of dapagliflozin on the rate of decline in kidney function
Teprotumumab for patients with active thyroid eye disease: a
Management of Thyroid Eye Disease: A Consensus Statement by the
de
por adulto (o preço varia de acordo com o tamanho do grupo)
